Delivery Order SPE2DR25D9113-SPE2DR26FCHY3
Award Date 2/17/26
Potential Completion Date 3/10/26
Potential Value $9.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price orders for pharmaceuticals and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,888.62. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, for YF-VAX 1 dose vials, with a ceiling value of $1,888.62. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for YF-VAX 1 dose vials, with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The order is issued under the company's single-award Indefinite Delivery Contract with DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $1,888.62 for YF-VAX 1 dose vials, with ultimate completion by February 27, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 17, 2026, with a ceiling value of $1,259.08 for YF-VAX 1 dose vials. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical products and medical consumables to support Department of Defense military...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for YF-VAX 1 Dose Vials with a ceiling value of $1,888.62. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion program authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a $3,147.70 delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed under a single-award Indefinite Delivery Contract with a $500 million ceiling awarded to DMS on November 13, 2025, with an ultimate completion date of December 31, 2036. PPV-G GEN V is a Defense...
- <p>The Defense Logistics Agency issued a $3,777.24 delivery order to DMS Pharmaceutical Group Inc. on February 7, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with an ultimate completion date of March 2, 2026. Place of performance is Park Ridge, IL.</p>
- <p>The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of March 3, 2026.</p>